EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitFallberichtOpen Access · CC BY 4.0

Case Series and Literature Review on Botulinum Toxin Efficacy in Axial Extensor Truncal Dystonia

Jarosław Sławek, Iga Alicja Łobińska, Michał Schinwelski iD, Joanna Kopcewicz-Wiśniewska, Anna Castagna iD

Toxins · 2025

DOI: 10.3390/toxins17080375 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Toxins, 2025. Verfasst von Jarosław Sławek und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neurological-Psychiatric Nursing, Faculty of Health Sciences, Medical University of Gdańsk, 80-210 Gdańsk, Poland. Hauptthemen laut MEDLINE: Botulinum Toxins, Type A, Dystonia, Dystonic Disorders, Neuromuscular Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Axial truncal dystonia can present as either flexion or extension, often with a tendency toward lateral movement. Flexion dystonia is more common and may represent a clinical spectrum associated with parkinsonism. In contrast, extensor trunk dystonia is less frequent and exhibits a diverse range of causes. In this paper, we reviewed the literature on axial extensor trunk dystonia. We identified 11 studies involving 49 patients, of which only 10 had idiopathic trunk dystonia. Treatment with botulinum neurotoxin A (BoNT/A) emerged as the most effective therapy; however, many studies did not provide detailed descriptions of the treatment (4/11) and follow-up periods were not specified or short term (up to one–two years). We present four new, well-documented patients with the idiopathic form of extensor trunk dystonia who were treated with BoNT/A with moderate to significant effect according to Global Clinical Impression scale (GCI) and Burke-Fahn-Marsden (BFM) dystonia scale. These cases include long-term follow-up for three patients, all without any adverse events. While the diagnostic process and treatment can be challenging, we recommend using BoNT/A with adjusted doses tailored to the appropriate muscle groups as a first-line treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Botulinum Toxins, Type ADystoniaDystonic DisordersNeuromuscular AgentsHumansMaleMiddle AgedFemaleTreatment OutcomeAgedAdult

Stichwörter der Autor:innen

axial dystoniaaxial extensor dystoniabotulinum neurotoxindystoniatruncal dystonia

Substanzen

Botulinum Toxins, Type ANeuromuscular Agents

Autor:innen und Institutionen

  • Division of Neurological-Psychiatric Nursing, Faculty of Health Sciences, Medical University of Gdańsk, 80-210 Gdańsk, Poland.
  • Department of Neurology & Stroke, St. Adalbert Hospital, Copernicus Ltd., 80-462 Gdańsk, Poland.
  • Medical Faculty, Medical University of Gdańsk, 80-210 Gdańsk, Poland.
  • Neurocentrum-Miwomed, Neurological Clinic, 80-207 Gdańsk, Poland.
  • IRCCS Fondazione Don Carlo Gnocchi, Onlus, 20162 Milan, Italy.

ORCID-Profile: Michał Schinwelski, Anna Castagna

Zitieren

APA

Sławek, J., Łobińska, I. A., Schinwelski, M., Kopcewicz-Wiśniewska, J., & Castagna, A. (2025). Case Series and Literature Review on Botulinum Toxin Efficacy in Axial Extensor Truncal Dystonia. Toxins. https://doi.org/10.3390/toxins17080375

Vancouver

Sławek J, Łobińska IA, Schinwelski M, Kopcewicz-Wiśniewska J, Castagna A. Case Series and Literature Review on Botulinum Toxin Efficacy in Axial Extensor Truncal Dystonia. Toxins. 2025. doi:10.3390/toxins17080375

BibTeX
@article{Sawek2025,
  author = {Sławek, Jarosław and Łobińska, Iga Alicja and Schinwelski, Michał and Kopcewicz-Wiśniewska, Joanna and Castagna, Anna},
  title = {Case Series and Literature Review on Botulinum Toxin Efficacy in Axial Extensor Truncal Dystonia},
  journal = {Toxins},
  year = {2025},
  doi = {10.3390/toxins17080375}
}
Kostenlos starten →